Market Tracker

10/24 3:31am ET

Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

9.15
Data as of Oct 23
 +0.03 / +0.33%
Today’s Change
1.68
Today|||52-Week Range
9.83
+263.10%
Year-to-Date

Today’s Trading

Previous close9.12
Today’s open9.19
Day’s range8.99 - 9.22
Volume456,242
Average volume (3 months)492,065
Market cap$347.0M
Dividend yield--
Data as of 3:59pm ET, 10/23/2014

Growth & Valuation

Earnings growth (last year)-1,300.00%
Earnings growth (this year)+20.71%
Earnings growth (next 5 years)+3.90%
Revenue growth (last year)+38.43%
P/E ratioNM
Price/Sales1.08
Price/Book3.06

Competitors

 Today’s
change
Today’s
% change
VVUSVIVUS Inc+0.08+2.41%
PETXAratana Therapeutics...+0.10+0.98%
VNDAVanda Pharmaceutical...+0.30+2.99%
SCMPSucampo Pharmaceutic...+0.41+5.12%
Data as of 3:59pm ET, 10/23/2014

Financials

Next reporting dateNovember 18, 2014
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$84.9M
Annual profit (last year)-$25.6M
Net profit margin-30.20%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Douglas L. Drysdale
Chief Operating Officer
Terence S. Novak
Corporate headquarters
Morristown, New Jersey

Forecasts